4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-22-039214
Chief Executive Officer sold 3,861 shares at $2.69 ($10,386)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-12-21 | Sale | −3,861 | $2.69 | $10,386 | 247,232 | D: show line 1 in the form |
| Open-market sales · 3,861 sh · avg $2.69 · $10,386 | |||||||
Loading xslF345X03/doc4.xml…